Microduplication of 15q13.3 and Xq21.31 in a family with tourette syndrome and comorbidities

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 8, 2013, Pages 825-831

  Melchior, Linea ^a   Bertelsen, Birgitte ^a   Debes, Nanette Mol ^b   Groth, Camilla ^b   Skov, Liselotte ^b   Mikkelsen, Jens D ^a   Brøndum Nielsen, Karen ^a   Tümer, Zeynep ^a  

^a Rigshospitalet   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ADHD; CHRFAM7A; CHRNA7; PABPC5; PCDH11X; Tourette syndrome

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; AUTOSOME; CASE REPORT; CHILD; CHROMOSOME 15Q13.3; CHROMOSOME ANALYSIS; CHROMOSOME XQ21.31; CLINICAL EXAMINATION; COMORBIDITY; COPY NUMBER VARIATION; FUSION GENE; GENE DUPLICATION; GILLES DE LA TOURETTE SYNDROME; HUMAN; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SCHOOL CHILD; SEASONAL AFFECTIVE DISORDER; TIC; X CHROMOSOME INACTIVATION;

ADHD; CHRFAM7A; CHRNA7; PABPC5; PCDH11X; TOURETTE SYNDROME;

CHILD; CHROMOSOME DUPLICATION; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, X; COMORBIDITY; FAMILY; FEMALE; HUMANS; MALE; PEDIGREE; POLYMERASE CHAIN REACTION; TOURETTE SYNDROME;

EID: 84887094233     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32186     Document Type: Article

References (40)

1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. 1992. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 51:1229-1239.
2. Araud T, Graw S, Berger R, Lee M, Neveu E, Bertrand D, Leonard S. 2011. The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function. Biochem Pharmacol 82:904-914.
3. Berg DK, Conroy WG. 2002. Nicotinic alpha 7 receptors: Synaptic options and downstream signaling in neurons. J Neurobiol 53:512-523.
4. Bertelsen B, Tümer Z, Ravn K. 2011. Three new loci for determining x chromosome inactivation patterns. J Mol Diagn 13:537-540.
5. Blanco P, Sargent CA, Boucher CA, Mitchell M, Affara NA. 2000. Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain. Mamm Genome 11:906-914.
6. Blanco P, Sargent CA, Boucher CA, Howell G, Ross M, Affara NA. 2001. A novel poly(A)-binding protein gene (PABPC5) maps to an X-specific subinterval in the Xq21.3/Yp11.2 homology block of the human sex chromosomes. Genomics 74:1-11.
7. Blanco-Arias P, Sargent CA, Affara NA. 2004. Protocadherin X (PCDHX) and Y (PCDHY) genes; multiple mRNA isoforms encoding variant signal peptides and cytoplasmic domains. Mamm Genome 15:41-52.
8. Chilian B, Abdollahpour H, Bierhals T, Haltrich I, Fekete G, Nagel I, Rosenberger G, Kutsche K. 2013. Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci. Clin Genet Jan 25 [Epub ahead of print].
9. Clarke RA, Lee S, Eapen V. 2012. Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism. Transl Psychiatry 2:e158.
10. de Lucas-Cerrillo AM, Maldifassi MC, Arnalich F, Renart J, Atienza G, Serantes R, Cruces J, Sánchez-Pacheco A, Andrés-Mateos E, Montiel C. 2011. Function of partially duplicated human alpha7 nicotinic receptor subunit CHRFAM7A gene: Potential implications for the cholinergic anti-inflammatory response. J Biol Chem 286:594-606.
11. Debes NM, Hjalgrim H, Skov L. 2008. Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome. J Child Neurol 23:1017-1027.
12. Fernandez TV, Sanders SJ, Yurkiewicz IR, Ercan-Sencicek AG, Kim YS, Fishman DO, Raubeson MJ, Song Y, Yasuno K, Ho WS, Bilguvar K, Glessner J, Chu SH, Leckman JF, King RA, Gilbert DL, Heiman GA, Tischfield JA, Hoekstra PJ, Devlin B, Hakonarson H, Mane SM, Günel M, State MW. 2012. Rare copy number variants in Tourette syndrome disrupts genes in histaminergic pathways and overlap with autism. Biol Psychiatry 71:392-402.
13. Flomen RH, Collier DA, Osborne S, Munro J, Breen G, St Clair D, Makoff AJ. 2006. Association study of CHRFAM7A copy number and 2-bp deletion polymorphisms with schizophrenia and bipolar affective disorder. Am J Med Genet Part B 141B:571-575.
14. Flomen RH, Davies AF, Di Forti M, La Cascia C, Mackie-Ogilvie C, Murray R, Makoff AJ. 2008. The copy number variant involving part of the alpha7 nicotinic receptor gene contains a polymorphic inversion. Eur J Hum Genet 16:1364-1371.
15. Flomen RH, Shaikh M, Walshe M, Schulze K, Hall MH, Picchioni M, Rijsdijk F, Toulopoulou T, Kravariti E, Murray RM, Asherson P, Makoff AJ, Bramon E. 2013. Association between the 2-bp deletion polymorphism in the duplicated version of the alpha7 nicotinic receptor gene and P50 sensory gating. Eur J Hum Genet 21:76-81.
16. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. 2000. An international perspective on Tourette syndrome: Selected findings from 3, 500 individuals in 22 countries. Dev Med Child Neurol 42:436-447.
17. Helbig I, Mefford HC, Sharp AJ, Guipponi M, Fichera M, Franke A, Muhle H, de Kovel C, Baker C, von Spiczak S, Kron KL, Steinich I, Kleefuss-Lie AA, Leu C, Gaus V, Schmitz B, Klein KM, Reif PS, Rosenow F, Weber Y, Lerche H, Zimprich F, Urak L, Fuchs K, Feucht M, Genton P, Thomas P, Visscher F, de Haan GJ, Møller RS, Hjalgrim H, Luciano D, Wittig M, Nothnagel M, Elger CE, Nürnberg P, Romano C, Malafosse A, Koeleman BP, Lindhout D, Stephani U, Schreiber S, Eichler EE, Sander T. 2009. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 41:160-162.
18. Hoppman-Chaney N, Wain K, Seger P, Superneau D, Hodge J. 2013. Identification of single gene deletions at 15q13.3: Further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype. Clin Genet 83:345-351.
19. Kitsiou-Tzeli S, Frysira H, Giannikou K, Syrmou A, Kosma K, Kakourou G, Leze E, Sofocleous C, Kanavakis E, Tzetis M. 2012. Microdeletion and microduplication 17q21.31 plus an additional CNV, in patients with intellectual disability, identified by array-CGH. Gene 492:319-324.
20. Lambson B, Affara NA, Mitchell M, Ferguson-Smith MA. 1992. Evolution of DNA sequence homologies between the sex chromosomes in primate species. Genomics 14:1032-1040.
21. Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, Huguet G, Konyukh M, Chaste P, Ey E, Rastam M, Anckarsäter H, Nygren G, Gillberg IC, Melke J, Toro R, Regnault B, Fauchereau F, Mercati O, Lemière N, Skuse D, Poot M, Holt R, Monaco AP, Järvelä I, Kantojärvi K, Vanhala R, Curran S, Collier DA, Bolton P, Chiocchetti A, Klauck SM, Poustka F, Freitag CM, Waltes R, Kopp M, Duketis E, Bacchelli E, Minopoli F, Ruta L, Battaglia A, Mazzone L, Maestrini E, Sequeira AF, Oliveira B, Vicente A, Oliveira G, Pinto D, Scherer SW, Zelenika D, Delepine M, Lathrop M, Bonneau D, Guinchat V, Devillard F, Assouline B, Mouren MC, Leboyer M, Gillberg C, Boeckers TM, Bourgeron T. 2012. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8:e1002521.
22. Leckman JF, Bloch MH, Scahill L, King RA. 2006. Tourette syndrome: The self under siege. J Child Neurol 21:642-649.
23. Liao J, DeWard SJ, Madan-Khetarpal S, Surti U, Hu J. 2011. A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features. Am J Med Genet Part A 155A:2795-2800.
24. Locke DP, Archidiacono N, Misceo D, Cardone MF, Deschamps S, Roe B, Rocchi M, Eichler EE. 2003. Refinement of a chimpanzee pericentric inversion breakpoint to a segmental duplication cluster. Genome Biol 4:R50.
25. Lopes AM, Ross N, Close J, Dagnall A, Amorim A, Crow TJ. 2006. Inactivation status of PCDH11X: Sexual dimorphisms in gene expression levels in brain. Hum Genet 119:267-275.
26. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM. 2009. Finding the missing heritability of complex diseases. Nature 461:747-753.
27. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y, Thiruvahindrapduram B, Fiebig A, Schreiber S, Friedman J, Ketelaars CE, Vos YJ, Ficicioglu C, Kirkpatrick S, Nicolson R, Sloman L, Summers A, Gibbons CA, Teebi A, Chitayat D, Weksberg R, Thompson A, Vardy C, Crosbie V, Luscombe S, Baatjes R, Zwaigenbaum L, Roberts W, Fernandez B, Szatmari P, Scherer SW. 2008. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82:477-488.
28. Miller DT, Shen Y, Weiss LA, Korn J, Anselm I, Bridgemohan C, Cox GF, Dickinson H, Gentile J, Harris DJ, Hegde V, Hundley R, Khwaja O, Kothare S, Luedke C, Nasir R, Poduri A, Prasad K, Raffalli P, Reinhard A, Smith SE, Sobeih MM, Soul JS, Stoler J, Takeoka M, Tan WH, Thakuria J, Wolff R, Yusupov R, Gusella JF, Daly MJ, Wu BL. 2009. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 46:242-248.
29. Nag A, Bochukova EG, Kremeyer B, Campbell DD, Muller H, Valencia-Duarte AV, Cardona J, Rivas IC, Mesa SC, Cuartas M, Garcia J, Bedoya G, Cornejo W, Herrera LD, Romero R, Fournier E, Reus VI, Lowe TL, Farooqi IS, Tourette Syndrome Association International Consortium for Genetics, Mathews CA, McGrath LM, Yu D, Cook E, Wang K, Scharf JM, Pauls DL, Freimer NB, Plagnol V, Ruiz-Linares A, 2013. CNV analysis in Tourette syndrome implicates large genomic rearrangements in COL8A1 and NRXN1. PLoS ONE 8:e59061.
30. O'Rourke J, Scharf JM, Yu D, Pauls DL. 2009. The genetics of Tourette syndrome: A review. J Psychosom Res 67:533-545.
31. Paschou P. 2013. The genetic basis of Gilles de la Tourette Syndrome. Neurosci Biobehav Rev 37:1026-1039.
32. Redies C, Vanhalst K, Roy F. 2005. delta-Protocadherins: Unique structures and functions. Cell Mol Life Sci 62:2840-2852.
33. Redies C, Hertel N, Hübner CA. 2012. Cadherins and neuropsychiatric disorders. Brain Res 1470:130-144.
34. Riley B, Williamson M, Collier D, Wilkie H, Makoff A. 2002. A 3-Mb map of a large segmental duplication overlapping the alpha7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14. Genomics 79:197-209.
35. Robertson MM, Eapen V, Cavanna AE. 2009. The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: A cross-cultural perspective. J Psychosom Res 67:475-483.
36. Sinkus ML, Lee MJ, Gault J, Logel J, Short M, Freedman R, Christian SL, Lyon J, Leonard S. 2009. A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res 29:1-11.
37. van Bon BW, Mefford HC, Menten B, Koolen DA, Sharp AJ, Nillesen WM, Innis JW, de Ravel TJ, Mercer CL, Fichera M, Stewart H, Connell LE, Ounap K, Lachlan K, Castle B, Van der Aa N, van Ravenswaaij C, Nobrega MA, Serra-Juhé C, Simonic I, de Leeuw N, Pfundt R, Bongers EM, Baker C, Finnemore P, Huang S, Maloney VK, Crolla JA, van Kalmthout M, Elia M, Vandeweyer G, Fryns JP, Janssens S, Foulds N, Reitano S, Smith K, Parkel S, Loeys B, Woods CG, Oostra A, Speleman F, Pereira AC, Kurg A, Willatt L, Knight SJ, Vermeesch JR, Romano C, Barber JC, Mortier G, Pérez-Jurado LA, Kooy F, Brunner HG, Eichler EE, Kleefstra T, de Vries BB. 2009. Further delineation of the 15q13 microdeletion and duplication syndromes: A clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 46:511-523.
38. Walsh T, McClellan J, McCarthy S, Addington A, Pierce S, Cooper G, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320:539-543.
39. Williams NA, Close JP, Giouzeli M, Crow TJ. 2006. Accelerated evolution of Protocadherin11X/Y: A candidate gene-pair for cerebral asymmetry and language. Am J Med Genet Part B 141B:623-633.
40. Williams NM, Franke B, Mick E, Anney RJ, Freitag CM, Gill M, Thapar A, O'Donovan MC, Owen MJ, Holmans P, Kent L, Middleton F, Zhang-James Y, Liu L, Meyer J, Nguyen TT, Romanos J, Romanos M, Seitz C, Renner TJ, Walitza S, Warnke A, Palmason H, Buitelaar J, Rommelse N, Vasquez AA, Hawi Z, Langley K, Sergeant J, Steinhausen HC, Roeyers H, Biederman J, Zaharieva I, Hakonarson H, Elia J, Lionel AC, Crosbie J, Marshall CR, Schachar R, Scherer SW, Todorov A, Smalley SL, Loo S, Nelson S, Shtir C, Asherson P, Reif A, Lesch KP, Faraone SV. 2012. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3. Am J Psychiatry 169:195-204.